| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Body-mass index and mortality among 1.46 million white adults.
|
N Engl J Med
|
2010
|
13.34
|
|
2
|
Work-related musculoskeletal disorders in physical therapists: a prospective cohort study with 1-year follow-up.
|
Phys Ther
|
2008
|
2.53
|
|
3
|
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
1.95
|
|
4
|
Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.67
|
|
5
|
Reproducibility of serum cytokines and growth factors.
|
Cytokine
|
2008
|
1.61
|
|
6
|
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
|
Int J Cancer
|
2004
|
1.52
|
|
7
|
A comparison of survival rates for treatment of melanoma metastatic to the brain.
|
Cancer Invest
|
2004
|
1.46
|
|
8
|
Circulating inflammation markers and risk of epithelial ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.44
|
|
9
|
Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
1.40
|
|
10
|
Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
|
Int J Cancer
|
2004
|
1.33
|
|
11
|
The potential protective effects of taurine on coronary heart disease.
|
Atherosclerosis
|
2009
|
1.27
|
|
12
|
Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.24
|
|
13
|
Targeted deletion of the genes encoding NTH1 and NEIL1 DNA N-glycosylases reveals the existence of novel carcinogenic oxidative damage to DNA.
|
DNA Repair (Amst)
|
2009
|
1.24
|
|
14
|
A pooled analysis of 12 cohort studies of dietary fat, cholesterol and egg intake and ovarian cancer.
|
Cancer Causes Control
|
2006
|
1.17
|
|
15
|
Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.
|
Eur Cytokine Netw
|
2009
|
1.16
|
|
16
|
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.
|
Cancer Causes Control
|
2010
|
1.14
|
|
17
|
Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
1.12
|
|
18
|
Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer.
|
Cancer Lett
|
2008
|
1.09
|
|
19
|
Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk.
|
Int J Cancer
|
2008
|
1.08
|
|
20
|
Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study.
|
Int J Cancer
|
2005
|
1.03
|
|
21
|
Circulating estrogen metabolites and risk for breast cancer in premenopausal women.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.02
|
|
22
|
Pesticide product use and risk of non-Hodgkin lymphoma in women.
|
Environ Health Perspect
|
2004
|
1.00
|
|
23
|
Non-vena cava venous leiomyosarcomas: a review of the literature.
|
Ann Surg Oncol
|
2012
|
1.00
|
|
24
|
Job strain in physical therapists.
|
Phys Ther
|
2009
|
1.00
|
|
25
|
Temporal reliability of cytokines and growth factors in EDTA plasma.
|
BMC Res Notes
|
2010
|
0.95
|
|
26
|
Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
|
Breast Cancer Res
|
2013
|
0.95
|
|
27
|
Reproducibility of serum pituitary hormones in women.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.95
|
|
28
|
Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.95
|
|
29
|
Fruits and vegetables and ovarian cancer risk in a pooled analysis of 12 cohort studies.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.92
|
|
30
|
Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.
|
Cancer Epidemiol
|
2012
|
0.92
|
|
31
|
Reliability of serum assays of iron status in postmenopausal women.
|
Ann Epidemiol
|
2006
|
0.89
|
|
32
|
Factors associated with inflammation markers, a cross-sectional analysis.
|
Cytokine
|
2011
|
0.89
|
|
33
|
Endogenous hormones and coronary heart disease in postmenopausal women.
|
Atherosclerosis
|
2011
|
0.89
|
|
34
|
Premenopausal serum androgens and breast cancer risk: a nested case-control study.
|
Breast Cancer Res
|
2012
|
0.89
|
|
35
|
IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies.
|
Eur J Cancer Prev
|
2005
|
0.87
|
|
36
|
Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States).
|
Cancer Causes Control
|
2002
|
0.87
|
|
37
|
Circulating vitamin d and risk of epithelial ovarian cancer.
|
J Oncol
|
2009
|
0.87
|
|
38
|
Management of Spitz nevi: a survey of dermatologists in the United States.
|
J Am Acad Dermatol
|
2002
|
0.87
|
|
39
|
Genetic variants in hormone-related genes and risk of breast cancer.
|
PLoS One
|
2013
|
0.85
|
|
40
|
History of antibiotic use and risk of non-Hodgkin's lymphoma (NHL).
|
Int J Cancer
|
2003
|
0.84
|
|
41
|
Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States).
|
Cancer Causes Control
|
2005
|
0.84
|
|
42
|
Circulating prolactin levels and risk of epithelial ovarian cancer.
|
Cancer Causes Control
|
2013
|
0.81
|
|
43
|
Circulating enterolactone and risk of endometrial cancer.
|
Int J Cancer
|
2006
|
0.80
|
|
44
|
Re: C-reactive protein and risk of breast cancer.
|
J Natl Cancer Inst
|
2008
|
0.80
|
|
45
|
Temporal reproducibility of taurine measurements in frozen serum of healthy postmenopausal women.
|
Br J Nutr
|
2010
|
0.79
|
|
46
|
Serum taurine and risk of coronary heart disease: a prospective, nested case-control study.
|
Eur J Nutr
|
2012
|
0.78
|